S&P 5007,713▲ 0.28%Nasdaq26,425▼ 0.02%Dow Jones52,496▲ 1.02%Nasdaq 10029,490▼ 0.13%VIX17.31▼ 6.13%US Dollar101.71▼ 0.27%Gold spot4,165▲ 0.21%WTI spot101.91▲ 1.04%
Stockholm Exchange · Sweden · Updated after 19 Oct 2026 close

Iconovo

ICO · Stockholm Exchange · prices in SEK
SEK 0.972▼ -0.006 (0.61%)
Research reportHistorical data

About Iconovo

Iconovo is a Swedish company based in Lund that develops inhaler devices for delivering medicines to the lungs. It designs dry powder inhalers and other inhalation platforms, including single-dose and multi-dose devices, and works with pharmaceutical partners that use these devices with their own drug formulations. Its customers are mainly drug developers and healthcare companies that need reliable inhalation technology for respiratory and other treatments, and the company supports them through development and licensing arrangements.

The shares are listed on the Stockholm Exchange in Sweden under the code ICO, and the price on this page is in Swedish kronor (SEK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

37/ 100
Market X-Ray · price-based
Weak price profile
Ranks #645 of 911 on the Stockholm Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Sweden yet.
TrendWeak
41/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-15.2%
From 52-week high-54.6%
MomentumWeak
38/100
Lagging most stocks on this exchange.
See the numbers →
3-month return3.6%
6-month return-19.0%
12-month, skipping last month-45.9%
Stability (higher is calmer)Weak
38/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)52.7%
Worst drawdown, 1 year (smaller is calmer)-56.4%
LiquidityWeak
27/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.08M SEK
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Sweden when fundamentals data for this market is added. All Sweden stocks.
Price trend
Below its 200-day average
Versus its 50- and 200-day averages
52-week range
0.870 – 2.160
Price is 8% of the way up
Returns
+3.6% 3m · −55.6% 1y
Price returns, dividends not included
RSI (14)
32
Neutral zone

Price chart

52-wk range 0.870 – 2.160 Daily closes, split-adjusted

Signals

50-day average1.195
200-day average1.146
Golden/death cross (60d)Golden, 15 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.071

Technical summary

Daily
Strongly bearish
3 bullish · 1 neutral · 12 bearish
Weekly
Strongly bearish
0 bullish · 1 neutral · 11 bearish
Monthly
Strongly bearish
1 bullish · 0 neutral · 7 bearish
Moving averages (daily)
SMA 101.05Bearish
EMA 101.04Bearish
SMA 201.14Bearish
EMA 201.11Bearish
SMA 501.20Bearish
EMA 501.15Bearish
SMA 1001.14Bearish
EMA 1001.16Bearish
SMA 2001.15Bearish
EMA 2001.31Bearish
Oscillators (daily)
RSI (14)32.37Neutral
MACD (12, 26)-0.07Bearish
Momentum (12)-23.16Bearish
Stochastic %K (14)20.00Bullish
Williams %R (14)-80.00Bullish
CCI (20)-125.8Bullish
Pivot points (classic, last session)
S3
0.84
S2
0.86
S1
0.92
Pivot
0.94
R1
1.00
R2
1.03
R3
1.08
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.

Prices are end-of-day closes in SEK. Educational only, not financial advice.